SCHEMBL780236

SCHEMBL780236

Nn1ccnc1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526468 0.82
SCHEMBL27510365 0.74
SCHEMBL8698383 0.74 PARP1 (0.41)
SCHEMBL13506146 0.73 RAB9A (0.54)
SCHEMBL3273322 0.73 SMN1; SMN2 (0.33)
SCHEMBL4352197 0.73
SCHEMBL114011 0.73
SCHEMBL27831516 0.73 SMN1; SMN2 (0.33)
SCHEMBL29663370 0.71 SMYD3 (0.40)
SCHEMBL151256 0.71 ALDH1A1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111253317-B 1-substituted-1H-imidazole-2-carboxylic acid compound 四川大学 2023-08-04 CN disclosed
CN-111187218-B Application of 1-substituted-1H-imidazole-2-carboxylic acid compound in preparation of metal beta-lactamase inhibitor 四川大学 2023-08-04 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-3999183-A1 COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF Ono Pharmaceutical Co., Ltd. (JP) 2022-05-25 EP disclosed
CN-111253317-A 1-substituted-1H-imidazole-2-carboxylic acid compound 四川大学 2020-06-09 CN disclosed
CN-111187218-A Application of 1-substituted-1H-imidazole-2-carboxylic acid compounds in preparation of metal β -lactamase inhibitor 四川大学 2020-05-22 CN disclosed
CN-104877001-A Antifungal Agents SCYNEXIS INC 2015-09-02 CN disclosed
CN-102176827-B Antifungal formulations SCYNEXIS INC 2015-05-20 CN disclosed
CN-103930422-A Heterocyclic compounds and their use INFINITY PHARMACEUTICALS INC 2014-07-16 CN disclosed
US-20120071628-A1 TOPICAL THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES COMPRISING COMPOUND CAPABLE OF BINDING SPECIFICALLY TO DNA SEQUENCE NIHON UNIVERSITY (JP) 2012-03-22 US disclosed
CN-102190794-A Method for synthesizing rigid chain polyamide and synthetic product thereof JUNMA TYRE CORD CO LTD 2011-09-21 CN disclosed
CN-102176827-A Antifungal formulations MERCK SHARP & DOHME 2011-09-07 CN disclosed
US-20110046070-A1 GENE EXPRESSION INHIBITOR SELECTIVE FOR MATRIX METALLOPROTEINASE-9 GENE NIHON UNIVERSITY (JP) 2011-02-24 US disclosed
EP-2266583-A1 GENE EXPRESSION INHIBITOR SELECTIVE FOR MATRIX METALLOPROTEINASE-9 GENE Nihon University (JP) 2010-12-29 EP disclosed
US-7807844-B2 TGF-β gene expression inhibitor NIHON UNIVERSITY (JP) 2010-10-05 US disclosed
US-20080103187-A1 Tgf-Beta Gene Expression Inhibitor GENTIER BIOSYSTEMS, INC. (JP) 2008-05-01 US disclosed